OCTREOTIDE INJECTION
STERIMAX INC
Quick answers
Is there a shortage of OCTREOTIDE INJECTION in Canada?
No. There is no current shortage of OCTREOTIDE INJECTION 200MCG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
OCTREOTIDE INJECTION
TEVA CANADA LIMITED
OCTREOTIDE ACETATE INJECTION - 200MCG/ML
SANDOZ CANADA INCORPORATED
Other Products
SANDOSTATIN
NOVARTIS PHARMACEUTICALS CANADA INC
OCTREOTIDE ACETATE INJECTION - 500MCG/ML
SANDOZ CANADA INCORPORATED
OCTREOTIDE ACETATE INJECTION - 50MCG/ML
SANDOZ CANADA INCORPORATED
OCTREOTIDE ACETATE INJECTION - 100MCG/ML
SANDOZ CANADA INCORPORATED
DIN
02560283
Strength
200MCG
Dosage Form
Solution
Route
Intravenous Subcutaneous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from STERIMAX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02358328
200MG · DIN 02538431
50MG · DIN 02456524
20MG · DIN 00723754
1MG · DIN 02492768
500MG · DIN 02483890
50000UNIT · DIN 02245571
10MG · DIN 02413639
0.05MG · DIN 02413620
10MG · DIN 02413647
7.5MG · DIN 02460645
7.5MG · DIN 02504979